You have 1 action to finish to complete your account. Craft your experience by picking your interest on the Personalisation Page
Rhinology
On demand events

CEORL-HNS 2022 | Underlying Inflammation in Patients With Severe/Uncontrolled CRSwNP

Profs. Philippe Gevaert and Eugenio De Corso discuss the role of type 2 inflammation in CRSwNP and recent evidence of biologic efficacy.

Philippe Gevaert
Eugenio De Corso
MD, PhD
Philippe Gevaert +1 more

On demand materials

Learning objectives

  • Review the role of type 2 inflammation in patients with CRSwNP, focusing on the type 2 mediators that can be targeted by biologics
  • Understand severe/uncontrolled CRSwNP, treatment options, monitoring of treatment, and shared decision-making with patients
  • Learn surgical and biological treatment efficacy data for severe/uncontrolled CRSwNP
  • Review efficacy, real-world effectiveness, and safety profiles of available biologics for patients with severe/uncontrolled CRSwNP

About these experts